首页> 外文期刊>Hepato-gastroenterology. >Comparison of Seven Prognostic Staging Systems in Patients who undergo Hepatectomy for Hepatocellular Carcinoma
【24h】

Comparison of Seven Prognostic Staging Systems in Patients who undergo Hepatectomy for Hepatocellular Carcinoma

机译:肝细胞癌肝切除术患者七个预后分期系统的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: Various staging systems containing both the tumor and liver function factors for hepatocellular carcinoma (HCC) have been proposed. The aim of this study was to evaluate the appropriate staging system in patients received hepatic resection for HCC.Methodology: The prognosis of the 235 patients who had undergone hepatectomy in these 15 years were analyzed according to the 7 staging systems, the Cancer of the Liver Italian Program (CLIP) score, the Barcelona Clinic Liver Cancer (BCLC) staging, the Groupe d'Etude et de Traitment du Carcinome Hepatocellulaire (GETCH) classification, the Chinese University Prognostic Index (CUPI) grade, the Japan Integrated Staging (JIS) score, modified JIS (m JIS) score, and Tokyo score. The capabilities to differentiate the postoperative survival between the neighboring score in each staging system were exam-ined. Statistical analyses of the log-rank test, linear trend test, likelihood ratio (LR) test, Akaike Information Criteria (AIC), and Harrels' c-index were used.Results: The patients were widely distributed in the most of the staging system with the exceptions of GETCH classification and CUPI grade where almost all patients were classified to only the two groups. CLIP, JIS, m JIS, and Tokyo scores significantly differentiated the postoperative survival rate between 2 or 3 neighboring scores, whereas other staging systems only did between one.Statistical evaluations of prognostic stratification by the LR test, AIC, and Harrels' c-index showed that the JIS score system was the best among the 7 staging systems.Conclusions: JIS score is the best staging system for HCC in patients who undergo hepatectomy.
机译:背景/目的:已经提出了包含肿瘤和肝功能因子的肝癌(HCC)的各种分期系统。这项研究的目的是评估接受肝切除术的肝癌患者的适当分期系统。方法:根据这7种分期系统,即肝癌,分析了这15年中235例接受肝切除的患者的预后。意大利课程(CLIP)评分,巴塞罗那临床肝癌(BCLC)分期,爱德华等癌症肝细胞癌分群(GETCH)分类,中国大学预后指数(CUPI)等级,日本综合分期(JIS)得分,修正的JIS(m JIS)得分和东京得分。检查了在每个分期系统中在相邻评分之间区分术后生存的能力。使用对数秩检验,线性趋势检验,似然比(LR)检验,Akaike信息标准(AIC)和Harrels c指数进行统计分析。结果:患者在大多数分期系统中分布广泛除了GETCH分类和CUPI分级外,几乎所有患者都被分为两组。 CLIP,JIS,m JIS和Tokyo评分在2或3个相邻评分之间显着区分了术后生存率,而其他分期系统仅在一个评分之间进行了区分。通过LR测试,AIC和Harrels c指数对预后分层进行统计学评估结果表明:JIS评分系统是7种分期系统中最好的。结论:JIS评分是肝切除患者肝癌最佳分期系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号